Dry Eye

There’s more to dry eye treatment than eye drops.

MeiboMetrics is scheduled to be available on several platforms starting in 2025.

Reproxalap was previously found to be statistically superior to vehicle for the primary endpoint of ocular discomfort (P=0.004) in a Phase 3 randomized, double-masked, vehicle-controlled dry eye chamber clinical trial.

Choosing the best lens is a puzzle that requires consideration of all the pieces.

Sabrina Gaan, OD, shares some of her most-used devices in her dry eye clinic and what helped her most in growing her specialized care.

The FDA and Palatin agreed on a clear regulatory path for PL9643 NDA submission in DED. The company hopes to start patient enrollment to start in the fourth quarter of calendar year 2024.

Understanding the latest innovative technologies.

Actionable tips to improve comfort and fit.

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, weigh in on meibomian gland dysfunction and dry eye disease what to consider when choosing symptom management options.

Adding a service to your practice can be scaled to your liking.

Results suggest higher exposures to lower temperatures and certain air pollutants could result in worsened ocular symptoms and increased tear osmolarity.

Vevizye was approved by the US FDA under the name Vevye in May 2023 for the treatment of moderate to severe dry eye disease.

The latest in market trends can offer insights into patient care.

The companies announced that they will be working to develop SGN’s micellar nanoparticle platform to be used with Eyenovia’s Optejet dispenser in a news release.

Increased pressure and inflammation require prompt treatment to avoid complications.

The collaboration agreement will allow the two companies to find a potential new treatment for chronic dry eye disease.

According to the company, the tuck-in acquisition will help expand its surgical presence in the United States and contribute to its leading position in dry eye.

The primary endpoint will be pain improvement as measured by visual analogue scale (VAS) compared to placebo.

The survey found that most participants may not know that their symptoms could be associated with eye dryness, including redness, fluctuating vision, a scratch, gritty, tired, or heavy feeling in the eye, or overall eye irritation.

Perfluorohexyloctane may slow evaporation to reduce dry eye.

Exploring strategies for effective management of a multifaceted condition.

The study also discovered a need for more blatant labeling on e-liquid containers to help reduce accidental contact with the ocular surface.

The company plans to finalize its Phase 3 development plans following an End-of-Phase 2 meeting with the FDA.

The solution, CAM360 AmnioGraft, is hydrated and shelf-stable without need for refrigeration.

The trial, in part of the ASTRO study, will evaluate the efficacy, safety, and tolerability of sterile ophthalmic ointment 0.5%.

One of the resources provided by the partnership is a Dry Eye Wheel, which provides mitigation, measurement, and management processes to inform the treatment of dry eye disease.

The study demonstrated sustained safety and efficacy of cyclosporine ophthalmic solution (Vevye) 0.1%, with many patients now entering their sixth refill cycle, according to the company.

The novel therapy for dry eye is a cross-linked hyaluronic acid derivative cleared by the FDA.

The launch of the nutritional supplement follows a clinical trial that demonstrated healthy tear production and provided noticeable relief of dry eye symptoms in as little as 2 to 4 weeks.